Report for: Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

Title	Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
Published in	Trials, April 2021
DOI	10.1186/s13063-021-05190-z
Pubmed ID	33845867
Authors	Nikhil Vergis, Rachel Phillips, Victoria Cornelius, Alexia Katsarou, Taryn Youngstein, Lucy Cook, Michelle Willicombe, Clio Pilay, Tina Shturova, Melanie Almonte, Asad Charania, Richard Turner, Onn Min Kon, Graham Cooke, Mark Thursz, Svetlana Cherlin, James Wason, Dragana Milojkovic, Andew J. Innes, Nichola Cooper

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.

Type	Count	As %
Members of the public	10	56%
Practitioners (doctors, other healthcare professionals)	6	33%
Scientists	2	11%

Mendeley readers

The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	184	100%

Readers by professional status	Count	As %
Student > Bachelor	25	14%
Student > Master	17	9%
Researcher	16	9%
Other	9	5%
Student > Doctoral Student	8	4%
Other	28	15%
Unknown	81	44%

Readers by discipline	Count	As %
Medicine and Dentistry	52	28%
Unspecified	8	4%
Nursing and Health Professions	7	4%
Psychology	5	3%
Social Sciences	3	2%
Other	20	11%
Unknown	89	48%

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial